greeksoup/ stock research
Stock research / United States / HCA · Services-General Medical & Surgical Hospitals, Nec · NYSE

HCA Healthcare, Inc. (HCA)

HCA Healthcare owns and operates hospitals and other care facilities. At 31 December 2025 it ran 190 hospitals, made up of 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centres and 31 freestanding endoscopy centres. The facilities sit in 19 states and England. The company commenced operations in 1968 through its predecessors, was incorporated in Delaware in October 2010 and is based in Nashville, Tennessee.

HCA Healthcare, Inc.

HCA Healthcare owns and operates hospitals and other care facilities. At 31 December 2025 it ran 190 hospitals, made up of 179 general acute care hospitals, seven behavioral hospitals and four rehabilitation hospitals, along with 121 freestanding ambulatory surgery centres and 31 freestanding endoscopy centres. The facilities sit in 19 states and England. The company commenced operations in 1968 through its predecessors, was incorporated in Delaware in October 2010 and is based in Nashville, Tennessee.

The hospitals

The 179 general acute care hospitals had 50,436 licensed beds at 31 December 2025. They provide medical and surgical services including inpatient care, intensive care, cardiac care, diagnostic services and emergency services, and outpatient services including outpatient surgery, laboratory, radiology, respiratory therapy, cardiology and physical therapy. They cover specialties such as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. Each hospital has an organised medical staff and a local board of trustees or governing board drawn from the community. The seven behavioral hospitals had 714 licensed beds and provide child, adolescent and adult psychiatric care and alcohol and drug abuse treatment and counselling.

Care outside the hospital

Outpatient and ancillary services are delivered through the acute care hospitals themselves and through ambulatory surgery centres, freestanding emergency care facilities, urgent care facilities, walk-in clinics, physician practices, diagnostic centres, home health agencies, hospices and rehabilitation facilities.

Who pays

Payment for patient services comes from the federal government through Medicare, from state governments through Medicaid and similar programmes, from managed care plans including those offered through federal and state health insurance marketplaces, from private insurers and directly from patients. By share of revenues in 2025, managed care and other insurers were 48.9%, managed Medicare 17.8%, Medicare 14.9%, Medicaid 7.8%, managed Medicaid 4.9%, international managed care and other insurers 2.5% and other, including uninsured patients, 3.2%. Medicare covers people aged 65 and over, some disabled people and people with end-stage renal disease or amyotrophic lateral sclerosis; Medicaid is a federal-state programme run by the states for qualifying low-income individuals. All of the company's general acute care hospitals in the United States are enrolled in both. The filing notes that amounts received under Medicare and Medicaid are generally much less than established hospital gross charges for the same services.

Strategy

The stated aim is to be the health care system of choice in the communities served by building comprehensive local networks and supporting them with enterprise expertise and scale. The growth agenda includes growing in existing markets, improving clinical, operational and satisfaction measures, attracting physicians and other health care professionals, developing more services, widening access and coordinating care across the network.

People

The workforce was approximately 320,000 employees at 31 December 2025, including approximately 90,000 part-time and as-needed employees. Human capital matters are overseen by the board and its committees through regular reporting from management and advisers.

From HCA Healthcare's annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in HCA Healthcare became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 29 October 2026
Revenue
$19.8 billion
+3.6% on the year · -1.9% on the quarter
Q4 FY2024Q3 FY2026
Net income
$1.6 billion
-3.9% on the year · -7.1% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$7.27
+4.5% on the year · -4.6% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Last full yearFY2025ended 31 December 2025 · 10-K filed 10 February 2026
Revenue
$75.6 billion
+7.1% on the year
FY2018FY2025
Net income
$6.8 billion
+17.8% on the year
FY2018FY2025
Diluted EPS
$28.33
+28.8% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsHCA Healthcare (HCA) reported revenue of $75.6 billion for fiscal 2025, the year ended 31 December 2025, up 7.1% on the year before. Net income was $6.8 billion and diluted earnings per share $28.33. Revenue was $70.6 billion in fiscal 2024, $65.0 billion in fiscal 2023, $60.2 billion in fiscal 2022 and $58.8 billion in fiscal 2021. Net income in the same years was $5.8 billion, $5.2 billion, $5.6 billion and $7.0 billion. Over the twelve months to 30 September 2026, HCA Healthcare reported revenue of $78.7 billion and net income of $6.8 billion. Revenue grew 8.0% a year, compounded, over the five years to fiscal 2025. HCA Healthcare declared $3.06 a share in dividends over the last four quarters and had 211 million shares outstanding at the latest filed count. At 30 September 2026 it carried $50.5 billion of debt and $908 million of cash. At the close of 6 November 2026 the market cap of HCA Healthcare was $104.4 billion, 16.4 times its earnings over the last twelve months.

Ratios

From the filings

ROEn/a
ROCEn/a
Operating margin12.5%
Net margin8.6%
FCF margin7.6%
Interest cover4.2x
Debt to equityn/a
Cash conversion1.65x
Share count, last 12 months-8.3%
Sales CAGR, 3 years7.9%
Profit CAGR, 3 years6.3%
EPS, TTM$30.18

At the close of 6 November 2026

Price$494.91
Market cap$104.4 billion
Stock P/E16.4x
Price to bookn/a
EV / EBITDA11.3x
Dividend yield0.6%
Market cap / sales1.3x
52-week high$545.13
52-week low$361.32
Price, 1 year5.0%
Price CAGR, 3 years28.5%
Price CAGR, 5 years14.8%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the total debt HCA Healthcare, Inc. states in its own filing, with lease liabilities counted separately and never inside it. Nothing here is a valuation or a view.
HCAgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022Q2 FY2022Q3 FY2022Q4 FY2022 *Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue15,06414,94514,82014,97115,49715,59115,86116,21317,30317,33917,49217,48718,28518,32118,60519,16119,51319,10920,23019,849
Operating income2,5861,8141,7601,7043,3021,9221,8091,6302,3452,2472,2371,9062,1332,3272,4152,4182,6722,2872,4942,370
Operating margin17%12%12%11%21%12%11%10%14%13%13%11%12%13%13%13%14%12%12%12%
Interest expense398408434446453479485483491512506515528547568561572584599607
Pre-tax income2,5861,8141,7601,7043,3021,9221,8091,6302,3452,2472,2371,9062,1332,3272,4152,4182,6722,2872,4942,370
Tax rate22%19%22%21%20%20%22%22%21%20%25%22%21%22%22%21%19%19%23%22%
Net income1,8141,2731,1551,1342,0811,3631,1931,0791,6071,5911,4611,2701,4381,6101,6531,6431,8781,6201,6991,579
Net margin12%9%8%8%13%9%8%7%9%9%8%7%8%9%9%9%10%8%8%8%
Diluted EPS$5.66$4.14$3.90$3.91$7.28$4.85$4.29$3.91$5.93$5.93$5.53$4.88$5.63$6.45$6.83$6.96$8.14$7.15$7.62$7.27
Operating cash flow2,4431,3451,6303,0202,5271,8032,4752,4792,6742,4691,9713,5152,5591,6514,2104,4162,3592,0142,3354,461
Capital expenditure1,1928611,0801,1311,3231,1971,2411,1471,1591,1181,2811,1911,2859911,1761,2881,4891,1191,2311,357
Free cash flow1,2514845501,8891,2046061,2341,3321,5151,3516902,3241,2746603,0343,1288708951,1043,104
Buybacks2,0722,1012,6826981,5198469151,1409101,1801,3671,7951,7002,5062,5052,4982,5581,5712,0642,970
Dividends paid148177160160156175164162160185171169165180171166162183171165
Shares outstanding305m299m287m284m277m276m273m269m266m263m259m255m250m243m236m230m225m223m218m211m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Revenue41,49043,61446,67751,33651,53358,75260,23364,96870,60375,60078,701
Operating income4,8104,3815,3355,2445,4309,8338,5807,7068,5239,8329,823
Operating margin11.6%10.0%11.4%10.2%10.5%16.7%14.2%11.9%12.1%13.0%12.5%
Interest expense1,7071,6901,7551,8241,5841,5661,7411,9382,0612,2482,362
Pre-tax income4,8104,3815,3355,2445,4309,8338,5807,7068,5239,8329,823
Income tax1,3781,6389461,0991,0432,1121,7461,6151,8662,0502,024
Effective tax rate28.6%37.4%17.7%21.0%19.2%21.5%20.3%21.0%21.9%20.9%20.6%
Net income2,8902,2163,7873,5053,7546,9565,6435,2425,7606,7846,776
Net margin7.0%5.1%8.1%6.8%7.3%11.8%9.4%8.1%8.2%9.0%8.6%
Diluted EPS$7.30$5.95$10.66$10.07$10.93$21.16$19.15$18.97$22.00$28.33$30.18
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Revenue by segment FY2016 to FY2025

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025Share
of the parts, latest year
American Group19,67020,91221,95923,17323,59319,63620,85822,31824,66826,44535.0%
Atlantic Groupn/an/an/an/an/a19,09819,32421,16723,38024,70932.7%
National Group19,84520,77222,58125,91325,69416,32916,76718,10519,65621,27828.1%
Corporate and Other1,9751,9302,1372,2502,2463,6893,2843,3782,8993,1684.2%
American GroupAtlantic Group FY2021 to FY2025National GroupCorporate and Other
43.6FY201751.3FY201958.8FY202165.0FY202375.6FY2025

$ billion; hover a block for its figure and share; a part named with years is one the company split its revenue into only then

From the company's 10-Ks, in its own words (latest 10-K).
Read moreEach year's figures come from the most recent 10-K that includes that year. A year is shown only where the parts add up to the revenue above. Fiscal years are labelled by the year they end in.

Cash flow

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Operating cash flow5,6535,4266,7617,6029,2328,9598,5229,43110,51412,63611,169
Capital expenditure2,7603,0153,5734,1582,8353,5774,3954,7444,8754,9445,196
Free cash flow2,8932,4113,1883,4446,3975,3824,1274,6875,6397,6925,973
Free cash flow margin7.0%5.5%6.8%6.7%12.4%9.2%6.9%7.2%8.0%10.2%7.6%
Cash from investing-3,240-4,279-3,901-5,720-3,393-2,643-3,389-5,317-4,933-4,988-6,072
Cash from financing-2,508-1,061-3,075-1,771-4,677-6,655-5,656-4,094-4,582-8,550-5,182
Depreciation and amortisation1,9662,1312,2782,5962,7212,8532,9693,0773,3123,5233,739
Share-based compensation251270268347362440341262360401404
Buybacks2,7512,0511,5301,0314418,2157,0003,8116,04210,0679,163
Dividends paidn/a0.0487550153624653661690679681
Dividend per sharen/an/a$1.40$1.60$0.43$1.92$2.24$2.40$2.64$2.88$3.06
Diluted shares, weighted396m372m355m348m344m329m295m276m262m239m217m
Shares outstanding at period end371m350m343m338m339m305m277m266m250m225m211m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTM
Funded by
Shareholders' equity-7,302-6,806-4,950-2,808572-933-2,767-1,774-2,499-6,027-8,077
Non-controlling interest1,6691,8112,0322,2432,3202,4222,6942,8343,0543,2563,478
Debt31,37633,05832,82133,72231,00434,57938,08439,59343,03146,49250,493
Operating lease liabilitiesn/an/an/a1,4991,6731,7551,7521,9031,8631,8531,933
Finance lease liabilitiesn/an/an/a470494577579541624625n/a
Other liabilities8,0158,5309,3049,93211,42712,34212,09613,11413,44014,52115,625
Total liabilities and equity33,75836,59339,20745,05847,49050,74252,43856,21159,51360,72063,452
Owned
Fixed assets16,35217,89519,75722,71523,19924,06325,57527,71529,41431,14132,268
Investments385472409462504541381477569485463
Cash and equivalents6467325026211,7931,4519089351,9331,040908
Receivables5,8266,5016,7897,3807,0518,0958,8919,95810,75110,86711,509
Inventory1,5031,5731,7321,8492,0251,9862,0682,0211,7381,6521,670
Other assets9,0469,42010,01812,03112,91814,60614,61515,10515,10815,53516,634
Total assets33,75836,59339,20745,05847,49050,74252,43856,21159,51360,72063,452
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compoundedn/a8.0%7.9%5.8%
Profit growth, compoundedn/a12.6%6.3%6.8%
Return on equity, averagen/an/an/an/a
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was HCA Healthcare's revenue in fiscal 2025?

HCA Healthcare (HCA) reported revenue of $75.6 billion for fiscal 2025, the year ended 31 December 2025, up 7.1% on the year before.

How much did HCA Healthcare earn in fiscal 2025?

Net income was $6.8 billion for fiscal 2025, and diluted earnings per share $28.33.

What is HCA Healthcare's P/E ratio?

At the close of 6 November 2026, HCA Healthcare traded at 16.4 times its earnings over the twelve months to 30 September 2026.

What is HCA Healthcare's market cap?

The market cap of HCA Healthcare was $104.4 billion at the close of 6 November 2026.

Does HCA Healthcare pay a dividend?

Yes. HCA Healthcare declared $3.06 a share in dividends over the four quarters to 30 September 2026.

Peers: Healthcare

CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
HCA Healthcare, Inc. HCA$104.4 billion16.40n/a12.5%5.8%n/a0.6%
Natera, Inc. NTRA$44.9 billionn/a-8.8%-9.0%37.4%0.04n/a
Labcorp Holdings Inc. LH$29.8 billion30.0811.3%10.3%6.0%0.660.8%
Quest Diagnostics Inc. DGX$28.1 billion25.4614.8%14.6%9.1%0.731.3%
Tenet Healthcare Corp. THC$22.6 billion8.2253.3%24.4%6.2%2.43n/a
Guardant Health, Inc. GH$20.4 billionn/an/a-39.4%41.7%n/an/a
Encompass Health Corp. EHC$13.5 billion21.4924.0%18.3%9.4%0.970.6%
BrightSpring Health Services, Inc. BTSG$13.4 billion36.3118.8%3.4%22.9%1.00n/a
Universal Health Services Inc. UHS$11.3 billion8.1819.2%10.8%8.0%0.750.4%
Surgery Partners, Inc. SGRY$3.0 billionn/a-5.3%11.4%4.0%2.25n/a
Ardent Health, Inc. ARDT$2.4 billion16.7910.5%4.5%2.0%0.79n/a
Community Health Systems Inc. CYH$311 million8.48n/a10.9%-7.8%n/an/a
All 59 in Healthcare
CompanyMarket capP/EROEOp. marginSales growth
TTM
Debt to equityDiv. yield
HCA Healthcare, Inc. HCA$104.4 billion16.40n/a12.5%5.8%n/a0.6%
Natera, Inc. NTRA$44.9 billionn/a-8.8%-9.0%37.4%0.04n/a
Labcorp Holdings Inc. LH$29.8 billion30.0811.3%10.3%6.0%0.660.8%
Quest Diagnostics Inc. DGX$28.1 billion25.4614.8%14.6%9.1%0.731.3%
Tenet Healthcare Corp. THC$22.6 billion8.2253.3%24.4%6.2%2.43n/a
Guardant Health, Inc. GH$20.4 billionn/an/a-39.4%41.7%n/an/a
Encompass Health Corp. EHC$13.5 billion21.4924.0%18.3%9.4%0.970.6%
BrightSpring Health Services, Inc. BTSG$13.4 billion36.3118.8%3.4%22.9%1.00n/a
Davita Inc. DVA$12.1 billion14.09n/a15.0%6.4%n/an/a
Universal Health Services Inc. UHS$11.3 billion8.1819.2%10.8%8.0%0.750.4%
Ensign Group, Inc. ENSG$10.6 billion26.9615.6%9.0%17.5%0.080.1%
Pacs Group, Inc. PACS$7.9 billion28.8122.9%7.4%12.4%0.22n/a
Caris Life Sciences, Inc. CAI$7.2 billion76.4515.0%13.4%n/a0.61n/a
Chemed Corp. CHE$6.9 billion25.2732.8%13.9%5.2%0.270.5%
Hims & Hers Health, Inc. HIMS$6.1 billionn/a-43.8%-6.0%28.0%4.21n/a
RadNet, Inc. RDNT$6.0 billionn/a-1.9%3.1%18.9%1.22n/a
BillionToOne, Inc. BLLN$5.4 billion104.298.7%10.2%n/a0.16n/a
Grail, Inc. GRAL$5.4 billionn/a-16.6%-347.3%17.5%0.00n/a
Concentra Group Holdings Parent, Inc. CON$5.3 billion24.9642.7%16.9%11.8%3.000.6%
LifeStance Health Group, Inc. LFST$5.2 billion72.474.8%6.2%22.6%0.18n/a
Option Care Health, Inc. OPCH$4.7 billion22.7716.2%5.9%4.0%0.87n/a
Sotera Health Co. SHC$4.6 billion26.6823.7%n/a6.9%2.91n/a
CareDx, Inc. CDNA$4.1 billion32.8627.5%23.4%38.9%0.00n/a
Acadia Healthcare Company, Inc. ACHC$3.4 billionn/a-55.8%-31.7%4.5%1.16n/a
National Healthcare Corp. NHC$3.3 billion28.7610.2%9.8%5.6%0.451.3%
Privia Health Group, Inc. PRVA$3.1 billion93.924.3%2.1%19.2%0.00n/a
Surgery Partners, Inc. SGRY$3.0 billionn/a-5.3%11.4%4.0%2.25n/a
Aveanna Healthcare Holdings, Inc. AVAH$2.9 billion10.7695.6%10.5%19.5%4.52n/a
Progyny, Inc. PGNY$2.6 billion31.9622.0%9.4%5.5%0.00n/a
Pediatrix Medical Group, Inc. MD$2.4 billion17.0017.7%10.9%1.9%0.68n/a
Ardent Health, Inc. ARDT$2.4 billion16.7910.5%4.5%2.0%0.79n/a
Addus HomeCare Corp. ADUS$2.3 billion20.709.4%10.3%11.5%0.02n/a
Brookdale Senior Living Inc. BKD$2.2 billionn/an/a6.8%-8.4%n/an/a
Fortrea Holdings Inc. FTRE$2.1 billionn/a-12.9%0.5%-3.4%1.98n/a
Veracyte, Inc. VCYT$1.9 billion15.568.9%17.1%17.5%0.00n/a
agilon health, Inc. AGL$1.9 billion20.59-31.0%-2.6%2.0%0.11n/a
GeneDx Holdings Corp. WGS$1.9 billionn/a-43.5%-20.3%25.4%0.41n/a
Personalis, Inc. PSNL$1.7 billionn/a-56.1%-156.7%16.9%n/an/a
Healthcare Services Group Inc. HCSG$1.6 billion16.2919.7%n/a4.0%0.00n/a
Teladoc Health, Inc. TDOC$1.6 billionn/a-12.0%-6.6%-2.4%0.77n/a
Sonida Senior Living, Inc. SNDA$1.6 billionn/a-14.8%-11.8%70.0%1.88n/a
U S Physical Therapy Inc. USPH$1.5 billionn/a7.0%9.1%10.4%0.571.8%
Lumexa Imaging Holdings, Inc. LMRI$1.3 billionn/an/an/an/a1.36n/a
Pennant Group, Inc. PNTG$1.3 billion36.738.5%5.8%38.7%0.47n/a
InnovAge Holding Corp. INNV$1.2 billion149.673.5%1.4%15.1%0.19n/a
Castle Biosciences Inc. CSTL$1,000 millionn/a-4.8%-7.4%9.8%0.020.0%
AdaptHealth Corp. AHCO$999 millionn/a-33.2%-11.5%-3.2%1.54n/a
Omada Health, Inc. OMDA$936 million71.905.1%2.1%n/a0.00n/a
Starling Oncology, Inc. STLN$682 millionn/an/a-3.4%34.6%n/an/a
Fulgent Genetics, Inc. FLGT$660 millionn/a-9.2%-39.2%4.7%0.00n/a
SBC Medical Group Holdings Inc. SBC$522 million10.8318.6%37.3%-6.9%0.14n/a
Viemed Healthcare, Inc. VMD$348 million24.0510.4%7.8%21.8%0.03n/a
Community Health Systems Inc. CYH$311 million8.48n/a10.9%-7.8%n/an/a
Exagen Inc. XGN$141 millionn/a-154.9%-18.6%20.8%1.87n/a
LifeMD, Inc. LFMD$113 millionn/an/an/an/a0.00n/a
Sera Prognostics, Inc. SERA$112 millionn/a-63.8%-38,755.2%1.1%0.00n/a
Park Dental Partners, Inc. PARK$94 millionn/an/an/an/a0.37n/a
Biodesix Inc. BDSX$94 millionn/a-312.1%-18.7%31.2%5.76n/a
Airsculpt Technologies, Inc. AIRS$39 millionn/a-8.9%-4.7%-6.3%0.35n/a
5 companies share its SEC industry code (Services-General Medical & Surgical Hospitals, Nec); the rest are the names nearest in size in its wider industry, Healthcare, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on HCA

Dividends$3.06 a share over the four quarters to 30 September 2026, a 0.62% yield
Filings21 in twelve months: 13 current reports (8-K), about 9 other events; 5 results of operations; 5 regulation FD disclosure; 3 new financial obligation; 2 material agreement
Planned insider sales7 Form 144 notices in twelve months, $49.8 million; latest 4 November 2026
Options tapeput/call 1.2 by open interest at the 6 November 2026 close; the straddle prices a 5.7% move to 20 November 2026
13F holders1,348 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading21 sales and 0 purchases on Form 4 in twelve months
Congress1 House trade disclosed in six months
Short interest4.9 million shares short, 4.60 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 5 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 202629 October 2026EDGAR
10-Q30 June 202628 July 2026EDGAR
10-Q31 March 202629 April 2026EDGAR
10-K31 December 202510 February 2026EDGAR
10-Q30 September 202530 October 2025EDGAR
10-Q30 June 20254 August 2025EDGAR
10-Q31 March 20251 May 2025EDGAR
10-K31 December 202414 February 2025EDGAR
10-Q30 September 202431 October 2024EDGAR
10-Q30 June 202429 July 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.